Michael Dixon is a Managing Partner at Transformation Capital. See portfolio, sector focus and contact routes.
Michael Dixon is a Managing Partner at Transformation Capital, a San Francisco-based venture capital firm dedicated to healthcare, having previously spent over a decade as a partner at Sequoia Capital where he focused on healthcare investments. His investment thesis targets commercialized, growth-stage healthcare companies, typically entering at Series B or later to help businesses scale rather than find product-market fit. The firm generally invests between $10 million and $40 million over a company’s lifetime, with Dixon often participating in later-stage rounds within Health IT and SaaS. Notable portfolio companies in his track record include Health Catalyst, Clover Health, Datavant, and Cleo, all of which operate in the healthcare and data sectors. Dixon serves on the boards of Health Catalyst, Datavant, Grow Therapy, and Citizen Health, reflecting his active governance role in these growth-stage firms. While he has shared insights on digital health investing in interviews, emphasizing the startup ecosystem’s power to fix systemic healthcare issues, there is no widely cited public writing or distinctive published point of view beyond t
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in San Francisco.
Investors like Michael Dixon · Full investor directory · Investor access · Company funding database